TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yu, Hong Pei ^a   Xie, Jia Ming ^a   Li, Bin ^c   Sun, Yi Hui ^a   Gao, Quan Geng ^c   Ding, Zhi Hui ^b   Wu, Hao Rong ^a   Qin, Zheng Hong ^b  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c Department of General Surgery First Peoples Hospital of Wu Jiang   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATM PROTEIN, HUMAN; C12ORF5 PROTEIN, HUMAN; CDK5 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 5; EPIRUBICIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE OXYGEN METABOLITE; SIGNAL PEPTIDE;

CELL NUCLEUS; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DRUG EFFECTS; GENETICS; HEP-G2 CELL LINE; HUMAN; HYPOXIA; METABOLISM; PENTOSE PHOSPHATE CYCLE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 5; DNA DAMAGE; DNA REPAIR; EPIRUBICIN; HEP G2 CELLS; HUMANS; HYPOXIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NADP; PENTOSE PHOSPHATE PATHWAY; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84946190342     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09853     Document Type: Article

References (33)

1. Prendergast, A. M., Cruet-Hennequart, S., Shaw, G., Barry, F. P. and Carty, M. P. Activation of DNAdamage response pathways in humanmesenchymal stem cells exposed to cisplatin or gamma-irradiation. Cell Cycle 10, 3768-3777, DOI: 10.4161/cc.10.21.17972 (2011
2. Jackson, S. P. and Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071-1078, DOI: 10.1038/nature08467 (2009
3. Ahmad, I. M. et al. Mitochondrial O2-and H2O2 mediate glucose deprivationinduced stress in human cancer cells. J Biol Chem 280, 4254-4263 (2005
4. Aykin-Burns, N., Ahmad, I. M., Zhu, Y., Oberley, L. W. and Spitz, D. R. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 418, 29-37, DOI: 10.1042/BJ20081258 (2009
5. Cosentino, C., Grieco, D. and Costanzo, V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30, 546-555, DOI: 10.1038/emboj.2010.330 (2011
6. de Lope, C. R., Tremosini, S., Forner, A., Reig, M. and Bruix, J. Management of HCC. J Hepatol 56 Suppl 1, S75-87, DOI: 10.1016/S0168-8278(12)60009-9 (2012
7. Wang, R. et al. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology 58, 642-653, DIO: 10.1002/hep.26373 (2013
8. Llovet, J.M. and Bruix, J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37, 429-442 (2003
9. Llovet, J. M. et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 359, 1734-1739 (2002
10. Lo, C. M. et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35, 1164-1171 (2002
11. Marelli, L. et al. Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Inter Rad 30, 6-25 (2007
12. Woods, D. and Turchi, J. J. Chemotherapy induced DNA damage response: Convergence of drugs and pathways. Cancer Biol Ther 14, 379-389, DOI: 10.4161/cbt.23761 (2013
13. Hanahan, D. and Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674, DOI: 10.1016/j.cell.2011.02.013 (2011
14. Kim, C. H., Park, S. J. and Lee, S. H. A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation. J Pharmacol Exp Ther 303, 753-759 (2002
15. Li, M. et al. A TIGAR-regulated metabolic pathway is critical for protection of brain ischemia.J Neurosci 34, 7458-71, DOI: 10.1523/JNEUROSCI.4655-13.2014 (2014
16. Bensaad, K. et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120 (2006
17. Wanka, C., Steinbach, J. P. and Rieger, J. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by upregulating respiration and improving cellular redox homeostasis. J Biol Chem 287, 33436-33446 (2012
18. Won, K. Y. et al. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Hum Pathol 43, 221-228, DOI: 10.1016/j. humpath.2011.04.021 (2012
19. Xie, J. M. et al. TIGAR has a dual role in cancer cell survival through regulating apoptosis and autophagy. Cancer Res 74, 5127-38, DOI: 10.1158/0008-5472. CAN-13-3517 (2014
20. Zhang, W., Peng, G., Lin, S.-Y., and Zhang, P. DNA damage response is suppressed by the high cyclin-dependent kinase 1 activity in mitotic mammalian cells. J Biol Chem 286, 35899-35905, DOI: 10.1074/jbc.M111.267690 (2011
21. Burhans, W. C. and Heintz, N. H. The cell cycle is a redox cycle: Linking phasespecific targets to cell fate. Free Radic Biol Med 47, 1282-1293, DOI: 10.1016/j. freeradbiomed.2009.05.026 (2009
22. Lu, T. and Finkel, T. Free radicals and senescence. Exp Cell Res 314, 1918-1922, DOI: 10.1016/j.yexcr.2008.01.011 (2008
23. Sfikas, A. et al. The canonical NF-kappaB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage. Cell Signal 24, 2007-2023, DOI: 10.1016/j.cellsig.2012.06.010 (2012
24. Stracker, T. H., Roig, I., Knobel, P. A. and Marjanovic, M. The ATM signaling network in development and disease. Front Genet 4, 37, DOI: 10.3389/fgene.2013.00037 (2013
25. Courapied, S. et al. The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition. J Biol Chem 285, 26765-26778, DOI: 10.1074/jbc.M109.092304 (2010
26. Huang, E., Qu, D. B. and Park, D. S. Cdk5 Links to DNA damage. Cell Cycle 9, 3142-3143, DOI: 10.4161/cc.9.16.12955 (2010
27. Tian, B., Yang, Q. and Mao, Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 11, 211-8, DOI: 10.1038/ncb1829 (2009
28. Camins, A. et al. Calpains as a target for therapy of neurodegenerative diseases: Putative role of lithium. Curr Drug Metab 10, 433-447 (2009
29. Lee, J. H., Kim, H. S., Lee, S. J. and Kim, K. T. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci 120, 2259-2271 (2007
30. Aldoss, I. T., Tashi, T. and Ganti, A. K. Seliciclib in malignancies. Expert Opin Inv Drug 18, 1957-1965, DOI: 10.1517/13543780903418445 (2009
31. Krystof, V. and Uldrijan, S. Cyclin-dependent kinase inhibitors as anticancer drugs. Curr Drug Targets 11, 291-302 (2010
32. Helleday, T., Petermann, E., Lundin, C., Hodgson, B. and Sharma, R. A. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8, 193-204, DOI: 10.1038/nrc2342 (2008
33. Martin, S. A., Lord, C. J. and Ashworth, A. DNA repair deficiency as a therapeutic target in cancer. Curr Opin Genet Dev 18, 80-86, DOI: 10.1016/j.gde.2008.01.016 (2008).